Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The overall purpose of this study is to support the development of a DLX105 topical
formulation for the indication mild to moderate psoriasis vulgaris.